ORGANIC
LETTERS
2013
Vol. 15, No. 6
1370–1373
Diastereoselective Synthesis of Indanes
and Tetralins via Intramolecular
FriedelÀCrafts Reaction
Jeanne-Marie Begouin,† Francesca Capitta,† Xian Wu, and Meike Niggemann*
Institute of Organic Chemistry, RWTH Aachen University, Landoltweg 1,
52074 Aachen, Germany
Received February 5, 2013
ABSTRACT
An easy access to tetralin and indane skeletons has been developed using a diastereoselective intramolecular FriedelÀCrafts alkylation.
Treatment of diastereomeric mixtures of benzyl carbinols with a catalytic amount of Ca(NTf2)2/Bu4NPF6 yields the respective tetralin or indane in
good yields with high levels of regio- and diastereoselectivity.
Tetralin and indane ring structures are present in a wide
range of natural products and pharmaceuticals.1 A variety
of synthetic methods to synthesize these skeletons have
been explored.2 Although intramolecular FriedelÀCrafts
reactions of benzyl carbinols mediated by stoichiometric
protocol to the intramolecular FriedelÀCrafts6 reaction of
benzyl carbinols. The reaction starts with a dehydration of
the hydroxyl function yielding a carbocationic species I
(s. Scheme 1), a process which our calcium catalyst has
proven to promote particularly efficiently. This initially
formed carbocation I might cyclize directly with the arene
moiety. Alternatively, a prior rearrangement, either by a
amounts of Lewis and Brønsted acids (e.g., SnCl4, BF3
3
Et2O, and CF3CO2H) have been described,3 no catalytic
version of this reaction is known to date. Recently, we
developed a Ca(NTf2)2/Bu4NPF6 based catalyst system4
for the intermolecular alkylation of electron-rich arenes
using secondary and tertiary benzylic, allylic, and pro-
pargylic alcohols as environmentally benign alkylating
agents under very mild rt conditions.5 Hence, we became
interested in the possibility of extending the aforementioned
(3) (a) Khalaf, A. A.; Roberts, R. M. J. Org. Chem. 1972, 37, 4227. (b)
Roblin, R. O.; Marston, D., Jr.; Bogert, T. J. Am. Chem. Soc. 1935, 57, 151.
(c) Bright, S. T.; Coxon, J. M.; Steel, P. J. J. Org. Chem. 1990, 55, 1338. (d)
Banik, B. K.; Ghosh, S.; Ghatak, U. R. Tetrahedron 1988, 44, 6947. (e) Axon,
B. W.; Davis, R. B.; Woodgate, P. J. Chem. Soc., Perkin Trans. 1 1981, 2956.
(f) Nasipuri, D.; De Dalai, I. J. Chem. Soc., Perkin Trans. 1 1976, 19. (g)
Bogert, M. T.; Davidson, D.; Apfelbaum, P. M. J. Am. Chem. Soc. 1934, 56,
959. (h) Barrow, C. J.; Bright, S. T.; Coxon, J. M.; Steel, P. J. J. Org. Chem.
1989, 54, 2542. (i) Barclay, L. R. C.; Ginn, B. A.; Milligan, C. E. Can. J.
Chem. 1964, 42, 579. (j) Ganeshpure, P. A.; Stevenson, R. J. Chem. Soc.,
Perkin Trans. 1 1981, 1681. (k) Corey, E. J.; Luo, G.; Lin, L. S. Tetrahedron
Lett. 1998, 39, 2001. (l) Nagumo, S.; Miyoshi, I.; Akita, H.; Kawahara, N.
Tetrahedron Lett. 2002, 43, 2224. (m) Ziegler, F.; Schwartz, J. A. J. Org.
† These authors contributed equally.
(1) For examples of tetralins in medicinal chemistry, see: (a) Perrone, R.;
Berardi, F.; Colabufo, N. A.; Leopoldo, M.; Tortorella, V.; Fiorentini, F.;
Olgiati, V.; Ghiglieri, A.; Govoni, S. J. Med. Chem. 1995, 38, 943. (b)
Brewster, W. K.; Nichols, D. E.; Riggs, R. M.; Mottola, D. M.; Lovenberg,
T. W.; Lewis, M. H.; Mailman, R. B. J. Med. Chem. 1990, 33, 1756. For
examples of indanes in medicinal chemistry, see: (c) Gross, M. F.; Beaudoin,
S.; McNaughton-Smith, G.; Amato, G. S.; Castle, N. A.; Huang, C.; Zou,
A.; Yu, W. Bioorg. Med. Chem. Lett. 2007, 17, 2849.
€
Chem. 1978, 43, 985. (n) Muhlthau, F.; Bach, T. Synthesis 2005, 19, 3428.
(o) Khalaf, A. A.; Roberts, R. M. J. Org. Chem. 1969, 34, 3571. (p) Lednicer,
D.;Emmert,D.E.;Lyster,S.C.;Duncan,G.W.J. Med. Chem. 1969,12, 881.
(q) Bonnet-Delpon, D.; Cambillau, C.; Charpentier-Morize, M.; Jacquot, R.;
Mesureur, D.; Ourevitch, M. J. Org. Chem. 1988, 53, 754. (r) Angle, S. R.;
Louie, M. S. Tetrahedron Lett. 1989, 30, 5741. (s) Blum, R.; Giovannini, E.;
Hengartner, U.; Vallat, G. Helv. Chim. Acta 2002, 85, 1827–1840.
(4) (a) Haubenreisser, S.; Niggemann, M. Adv. Synth. Catal. 2011, 353,
469. (b) Meyer, V. J.; Niggemann, M. Eur. J. Org. Chem. 2011, 3671. (c)
Meyer, V. J.; Niggemann, M. Chem.;Eur. J. 2012, 18, 4687. (d) Niggemann,
M.; Bisek, N. Chem.;Eur. J. 2010, 16, 11246. (e) Niggemann, M.; Diba,
A. K.; Begouin, J.-M.; M. Tetrahedron Lett. 2012, 53, 6629.
(2) (a) Xie, K.; Wang, S.; Li, P.; Li, X. Tetrahedron Lett. 2010, 51,
4466. (b) Youn, S. W.; Pastine, S. J.; Sames, D. Org. Lett. 2004, 6, 581. (c)
Li, G.; Xiao, Q.; Li, C.; Wang, X.; Yin, D. Tetrahedron Lett. 2011, 52,
ꢀ
6827. (d) Sanchez-Larios, E.; Gravel, M. J. Org. Chem. 2009, 74, 7536.
(e) Chua, P. J.; Tan, B.; Yang, L.; Zeng, X.; Zhu, D.; Zhong, G. Chem.
Commun. 2010, 46, 7611.
r
10.1021/ol400341p
Published on Web 03/06/2013
2013 American Chemical Society